NCT06965621 - 18F-mFBG Imaging for Myocardial Sympathetic Innervation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

June 30, 2026

Conditions

Heart FailureIschemic CardiomyopathyICD Patients

Interventions

DRUG

18F-metaFluorobenzylguanidine

PET Radiopharmaceutical to assess myocardial sympathetic innervation

DRUG

Rubidium-82

PET Radiopharmaceutical to assess myocardial perfusion

Trial Locations (1)

UT Health Houston, Houston

All Listed Sponsors

collaborator

University of Texas

OTHER

lead

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)

INDUSTRY